Since the introduction of thiocarbamide derivatives for the treatment of thyrotoxicosis in 1943 there have been many reports alleging serious effects on human fetal thyroids when these drugs have been administered during pregnancy (Davis and Forbes, 1945; Hepner, 1952; Man, Shaver, and Cooke, 1958) . On the other hand, the delivery of normal infants after the controlled use of these drugs in pregnant hyperthyroid women has also been frequently described (Astwood, 1951; Piper and Rosen, 1954) . All of these observations have been made in the neonatal period, but the delivery of an apparently normal live-born infant at term does not necessarily indicate that the product of pregnancy is completely satisfactory. It is impossible either to recognize with certainty all congenital malformations at birth, or to evaluate the developmental capabilities of the infant at this time (Lowrey et al., 1958; Warkany and Kalter, 1961; Lock, Gatling, and Wells, 1961) . Only long-term follow-up can answer the question as to whether this therapy in the pregnant patient with thyrotoxicosis has any harmful effects on the subsequent development of the child. Two groups of workers (Greenman et al., 1962; Burrow et al., 1968) have already carried out such an assessment 1 to 10 years after delivery in children born to mothers treated with propylthiouracil during pregnancy. We report here the long-term evaluation of the offspring of thyrotoxic women treated during pregnancy with carbimazole (Neo-Mercazole), a chemically related antithyroid compound. (Tanner, Whitehouse, and Goldstein, 1972) .
Thyroid-function studies. Blood samples were taken from 24 of the children for determination of serum protein-bound iodine (PBI), free thyroxine index (FTI), tri-iodothyronine (T3), and thyroid stimulating hormone (TSH). The mother of Case 24 (Table I) refused  permission for venepuncture. PBI was measured with an autoanalyser, normal range 3*5-8*0 jig/100 ml. Serum thyroxine was estimated by competitive protein binding using Thyopac-4 (Amersham) and residual thyroid-hormone-binding capacity of serum measured by Thyopac-3 (Amersham), and the FTI was calculated (Bell et al., 1974) . The normal range for FTI was taken as 4-11. Serum T3 and TSH were measured by specific radioimmunoassay. The upper and lower limits of normality were derived from measurements made on the sera of 30 healthy matched control children who attended hospital for minor surgical procedures. For T3 the normal range lay between 100 and 260 ng/100 ml (mean 196-2±39-7 SD) and for TSH 0-5 to using the Buckinghamshire Screening Questionnaire (Shepherd, Oppenheim, and Mitchell, 1971) (Wechsler, 1949 (Wechsler, , 1967 Stutsman, 1948 (Crown and Crisp, 1966 Hospitalization. 10 of the 25 subjects had at some time required hospitalization. 8 admissions were for minor routine childhood ailments. One child required treatment as a neonate for Rhesus incompatibility and another had been investigated for failure to thrive, but both appeared to have achieved normal growth and development.
Behavioural health. Table II shows the incidence of behavioural problems in the 20 children of our group aged 5 to 15 years as compared with a control group of Northern Ireland children and the original Buckinghamshire group studied. Children under 5 years were excluded from this part of the study in the absence of reliable norms for comparative purposes. It will be seen that no child in our group, or in the Northern Ireland control group was free of behavioural problems. This contrasts markedly with the 40 *7% of problem-free children in the Buckinghamshire study and was statistically significant (X2 =12-06, P<0 01). 8 of the 20 children in our group (40%) and 6 of the Northern Ireland control children (30%) were regarded as deviant with a score of four or more behavioural problems, as compared with only 11-1% in the Buckinghamshire study. This again was significant (x2= 14 *03, P <0*001). Though the numbers are small it appears that the number of children with one, two, or three behavioural problems is similar in the two Northern Ireland groups at around 20 to 30%, but clearly lower in the Buckinghamshire study where 27 % had a problem score of one, while 15% scored two, and only 8% scored three. However, there was no statistical difference between scores in these three groups. tion for the year 1971 is 27 3/1000 total births, that of all eye abnormalities 0 2/1000, and that of limb reduction deformities 1 4/1000. Two malformations in a group of 25 suggests an incidence of abnormality 2 to 3 times greater than in other children in the region, but it is difficult to make valid deductions from such a small number. There are several possible aetiological explanations for these particular abnormalities. Firstly, they may be genetic in origin. It is well known that congenital cataracts and also certain skeletal limb deficiencies have predominantly genetic causes (Freire-Maia, 1969; Fraser, 1969) . Most of these, however, are associated with other multiple defects, while the 2 children in our study are otherwise normal. Further, there was no family history of malformations and both sibships were normal. Secondly, abnormal maternal thyroid hormone production, whether excessive or deficient, may have interfered with the developing fetal lens or limb bud at an early critical stage, i.e. 4-12 weeks' gestation. Neither the exact stage in pregnancy at which the human fetal thyroid is anatomically and functionally mature nor maternal/fetal thyroid hormone exchanges is as yet fully understood (Werner, 1967) . It must be assumed that until the fetal pituitary-thyroid system is mature the fetus depends to a varying extent on transplacental passage of thyroid hormones from its mother for normal development. Thyrotoxicosis per se has been variously reported either as having no injurious effects on the development of the offspring (Mussey, Plummer, and Boothby, 1926; Benson et al., 1959) or as being associated with a very high fetal wastage (45%) mainly due to the risks inherent in premature delivery, the incidence of which is raised in untreated mothers (GardinerHill, 1929; Mestman, Manning, and Hodgman, 1974) . It is generally accepted that pregnancy rarely occurs in the presence of active thyrotoxicosis (Freedberg, Hamolsky, and Freedberg, 1957; Javert, 1940) and the mothers of the affected children in our series had been diagnosed as thyrotoxic and were already on antithyroid therapy before pregnancy began. No relapse of their disease occurred at any stage of gestation. An excess of maternal thyroid hormone would therefore seem unlikely as an explanation for the abnormalities encountered.
In human hypothyroidism many studies have shown a high incidence of physical and mental abnormalities in the offspring, in particular permanent defects of the central nervous system (Man et al., 1958) . The mothers of both affected children in this series had remained apparently euthyroid throughout pregnancy on both clinical and laboratory criteria. However, clinical signs of mild hypothyroidism can easily be obscured by the physiological accompaniments of normal pregnancy, and PBI and T3 red cell uptake measurements are altered by the increase in thyroxine-binding globulin which occurs in pregnancy (Sterling and Brenner, 1966) . For this reason these tests have definite limitations as indices of the level of 'free' thyroxine, which is the functionally important fraction both to mother and fetus, and it is therefore impossible to be certain that mild episodes of undetected hypothyroidism did not occur from time to time in these women. Direct hormone assay, and in particular TSH estimation, gives more useful information on this point but has only recently become available. Finally, it is possible that carbimazole which crosses the placenta very readily (Hamburger, 1972) may itself have been directly toxic to the fetus. There are well recognized difficulties in documenting causal relations between environmental agents and birth defects in humans. With regard to drugs, only the thalidomide cases are well established, but recent reports have suggested an association between congenital limb reduction deformities and exposure to exogenous sex steroids during pregnancy (Janerich, Piper, and Glebatis, 1974; Nora and Nora, 1974; Jaffe et al., 1975) . In the context of our case it is of some interest that Janerich et al. (1974) have suggested that this association is not directly causal, but rather the result of some underlying endocrine abnormality in the mother, increasing the risk of her bearing an infant with this type of malformation.
The striking feature of psychological testing in our group of children is the marked increase in the number of behavioural problems which they manifested as compared with the original Buckinghamshire group. In view of the fact that the behavioural findings in our control group were almost identical, the most likely reason for this is simply that the Northern Ireland child population, and particularly those from the Belfast area from which most of the children studied came, may have different behavioural norms due to exposure to conditions of civil unrest from 1969 onwards.
This explanation is in keeping with evidence from recent local studies on child behaviour (Fraser, 1973) .
The evidence presented in our study suggests that the controlled use of carbimazole for thyrotoxicosis in pregnancy has no injurious effects on the subsequent growth and developmLnt of the child. Greenman et al. (1962) and Burrow et al. (1968) came to similar conclusions from their investigations of the use of propylthiouracil in pregnancy. The numbers in all of these studies have been small, making it difficult to reach definitive conclusions on such findings as congenital abnormalities and the possible teratogenic effect of antithyroid drugs in susceptible pregnancies. A multicentre prospective study designed to answer such problems seems desirable.
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